Skip to main content
. 2017 Jul 21;12(7):e0179831. doi: 10.1371/journal.pone.0179831

Table 1. Incidence of adverse events with donor characteristics.

Sample Adverse events No adverse events
n (%) n (%)
18,936 208 (1.1) 18,728(98.9)
Gender
Male 18,676 205 (1.1) 18,471(98.9)
Female 260 3 (1.2) 257 (98.8)
χ2 = 0.007, p = 0.931
Age (years)
<30 8,621 130 (1.5) 8491(98.5)
≥30 10,315 78 (0.8) 10,237(99.2)
χ2 = 24.30, p<0.001*
Weight (Kg)
<75 6,019 99 (1.6) 5,920(98.4)
≥75 12,917 109 (0.8) 12,808(99.2)
χ2 = 24.25, p<0.001*
Donation history
First time donor 9,010 144 (1.6) 8,866 (98.4)
Previous donor 9,926 64 (0.6) 9,862 (99.4)
χ2 = 39.38, p<0.001*
Hemoglobin level (g/dl)
12.5–13.0 440 2 (0.5) 438 (99.5)
13.1–14.0 1,641 12 (0.7) 1,629 (99.3)
14.1–15.0 3,381 23 (0.7) 3,358 (99.3)
> 15 13,474 171 (1.3) 13,303 (98.7)
χ2 = 12.77, p = 0.005*
Blood pressure
Normal/prehypertensive 14,860 167 (1.1) 14,693 (98.9)
Hypertension 4,076 41 (1.0) 4,035 (99.0)
χ2 = 0.410, p = 0.522

n: frequency,

%: percentage,

χ2: Chi-square,

p: p-value,

*: significance at <0.05, g/dl: gram per deciliter.